Advert - GW Pharmaceuticals

• Date posted
  08 August 2019
• Sanction
  Advertisement,
• Case number/s
  AUTH/3014/1/18 - Anonymous, non-contactable health professional v GW Pharmaceuticals

For promoting Epidiolex (cannabidiol) before the grant of a marketing authorization which permits its sale or supply, GW Pharmaceuticals was ruled in breach of the following clauses:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Clause 3.1 - Promoting an unlicensed medicine.

Clause 9.1 - Failing to maintain high standards.